Leporipoxvirus
Leporipoxvirus
Leporipoxvirus is a genus of viruses that primarily infects rabbits and hares. It belongs to the family Poxviridae, which includes several other genera of poxviruses. Leporipoxviruses are known to cause a variety of diseases in rabbits, ranging from mild to severe.
Taxonomy
Leporipoxvirus is classified under the subfamily Chordopoxvirinae, family Poxviridae, and order Caudovirales. The genus includes three recognized species: Rabbit fibroma virus (RFV), Myxoma virus (MYXV), and Shope fibroma virus (SFV). These viruses share similar characteristics but differ in their pathogenicity and host range.
Morphology
Leporipoxviruses are large, enveloped viruses with a complex structure. They have a brick-shaped morphology and measure approximately 200-300 nanometers in length. The viral particles contain a linear double-stranded DNA genome, which is enclosed within a protein coat called the nucleocapsid. The nucleocapsid is surrounded by an outer envelope derived from the host cell membrane.
Pathogenesis
Leporipoxviruses primarily infect rabbits and hares through direct contact with infected animals or contaminated materials. The viruses can enter the host's body through skin abrasions or mucous membranes. Once inside the host, the virus replicates within the cytoplasm of infected cells, leading to the formation of characteristic lesions.
The pathogenicity of leporipoxviruses varies among the different species. Rabbit fibroma virus (RFV) causes benign tumors known as fibromas, which typically develop on the skin or subcutaneous tissues. Myxoma virus (MYXV) is highly pathogenic and causes a severe disease called myxomatosis. Infected rabbits develop multiple skin tumors, edema, and systemic symptoms, often leading to death. Shope fibroma virus (SFV) causes fibromas similar to RFV but is less pathogenic.
Clinical Signs
Clinical signs of leporipoxvirus infection vary depending on the specific virus and the host's immune response. In general, infected rabbits may exhibit the following symptoms:
- Skin lesions: Raised, firm, and often ulcerated nodules or tumors on the skin or subcutaneous tissues. - Edema: Swelling of the face, eyelids, or extremities due to fluid accumulation. - Respiratory signs: In severe cases, rabbits may show respiratory distress, sneezing, and nasal discharge. - Systemic signs: Lethargy, anorexia, weight loss, and fever may be observed in advanced stages of infection.
Diagnosis
Diagnosing leporipoxvirus infections can be challenging due to the similarity of clinical signs with other diseases. However, several diagnostic methods can be employed, including:
- Histopathology: Examination of tissue samples under a microscope can reveal characteristic cellular changes associated with poxvirus infections. - Polymerase chain reaction (PCR): PCR can detect viral DNA in clinical samples, providing a specific and sensitive method for diagnosis. - Serology: Serological tests can detect antibodies produced by the host in response to the virus, indicating a previous or ongoing infection.
Treatment and Prevention
There is no specific antiviral treatment available for leporipoxvirus infections. Management of infected rabbits focuses on supportive care, including wound management, pain relief, and prevention of secondary bacterial infections.
Prevention of leporipoxvirus infections can be achieved through vaccination. Vaccines are available for some leporipoxviruses, such as myxomatosis caused by Myxoma virus. Vaccination programs are commonly implemented in areas where the disease is endemic or poses a significant threat to rabbit populations.
References
1. Fenner F, et al. (1989). "Poxviruses." In: Fields Virology. 2nd ed. Philadelphia: Lippincott-Raven Publishers. 2. Kerr PJ, et al. (2017). "Poxviruses of Rabbits." In: Rabbit Hemorrhagic Disease: Its Causes and Control. Springer International Publishing.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD